Last reviewed · How we verify

NCT05964426

Health Literacy of Parents Regarding Neonatal Jaundice

Recruiting now Last updated 23 July 2024
What this trial tests

trial testing Turkey Health Literacy Scale (TSOY-32) in Unspecified Fetal and Neonatal Jaundice in 170 participants. Currently enrolling.

Timeline
1 July 2024
Primary endpoint
20 July 2024
31 December 2024

Quick facts

Lead sponsorEge University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment170
Start date1 July 2024
Primary completion20 July 2024
Estimated completion31 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

18 and older, any sex, with Unspecified Fetal and Neonatal Jaundice. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted as a relational descriptive study to determine the health literacy level of parents with infants between 0-28 days of age regarding neonatal jaundice. The secondary aim of the study is to examine whether the health literacy levels of the parents differ with parent and infant descriptive characteristics and their knowledge about neonatal jaundice. In this study, answers to the following questions were sought. 1. What is the level of knowledge about neonatal jaundice among parents with infants between 0-28 days? 2. What is the level of health literacy of parents with infants between 0-28 days of age and is there a relationship between parent, infant identifying characteristics and knowledge about neonatal jaundice?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05964426.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing